Salem, NH, –ALPCO Diagnostics is pleased to announce their North American distribution agreement with Swedish assay development and manufacturing company Euro Diagnostica. As part of this agreement, ALPCO will have access to and distribute Euro Diagnostica’s comprehensive, high quality assay portfolio throughout North America. Products to note from this catalog include Euro Diagnostica’s gold standard […]
Agilent Technologies Inc. (NYSE: A) today announced its microarrays were used in a landmark prenatal research study published on Thursday in the New England Journal of Medicine. The three-year collaborative study, “Chromosomal microarray versus karyotyping for prenatal diagnosis,” represents a significant milestone in understanding prenatal abnormalities. Agilent SurePrint CGH microarrays were used for the majority […]
LAKE OSWEGO, Ore. and NEWCASTLE-UPON-TYNE, United Kingdom, — Galena Biopharma, Inc. (Nasdaq:GALE) and Leica Biosystems today announced a partnership to develop a companion diagnostic for Galena’s NeuVax™ (nelipepimut-S or E75) breast cancer therapeutic. Galena Biopharma is a United States based biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to […]
Today Roche Diagnostics and the US President’s Emergency Plan for AIDS Relief (PEPFAR) announced a public-private partnership to improve the capacity of laboratorians and strengthen laboratory systems in African nations highly impacted by HIV/AIDS. Valued at $12 million over five years, the goal of the partnership is to build institutional capacity of regional and national […]
SEATTLE & SAN ANTONIO — NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostic products, today announced positive results from the second clinical validation study of its in vitro diagnostic breast cancer assay based on the PAM50 gene expression signature. The study, which evaluated samples […]
SAN DIEGO, — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that the U.S. Patent and Trademark Office will issue U.S. Patent No. 8,340,916 on December 25, 2012 with claims to novel methods for detecting fetal aneuploidy using massively parallel sequencing. The patent is entitled Diagnosing Fetal Chromosomal […]
Hercules, CA —— Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today provided an update to its November 5th announcement that the company was awarded a three-year sole source group purchasing contract for its blood bank reagents from the Premier healthcare alliance. Bio-Rad […]
LEXINGTON, MA – Predictive Biosciences, an innovative developer of molecular diagnostic tests, today announced that the Company has developed a new next-generation sequencing (NGS) assay for the TP53 gene (encoding the p53 protein) that will enhance the clinical performance of its bladder cancer assay. The new CertNDxTM Bladder Cancer Assay incorporating TP53 is expected to […]
RADNOR, PA, – VWR International, LLC, a leading global laboratory supply and distribution company, announced today that it has acquired Labonord SAS and Switch BVBA, expanding the company’s cytology and histology portfolio in Europe. Based in Lille, France, Labonord is an independent supplier of consumables and chemicals and also represents a number of leading suppliers […]
SEATTLE, Wash. – NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostic products, today announced the completion of a $15.3 million Series E Preferred Stock issuance. New investors in the transaction included Morgan Stanley Expansion Capital and AllianceBernstein Alternative Investment Management Group. All previous venture […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
